Walvax Biotechnology Co., Ltd. (300142.SZ)
300142.SZ Stock Price Chart
Explore Walvax Biotechnology Co., Ltd. interactive price chart. Choose custom timeframes to analyze 300142.SZ price movements and trends.
300142.SZ Company Profile
Discover essential business fundamentals and corporate details for Walvax Biotechnology Co., Ltd. (300142.SZ) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
12 Nov 2010
Employees
2.39K
Website
https://www.walvax.comCEO
Wei Yao
Description
Walvax Biotechnology Co., Ltd., a biological pharmaceutical company, researches and develops, produces, and sells bio-medicine products in China. The company offers biomedicines, such as vaccines, blood products, and others. It provides Group A, C meningococcal polysaccharide conjugate vaccine for infants below or equal to 2 years preventing diseases, such as cerebrospinal meningitis and septicemia; Group A and C meningococcal polysaccharide vaccine for in adults and children over the age of 2 years and adults to prevent disease caused by the bacterium Neisseria meningitidis group A or group C; and Group ACYW135 meningococcal polysaccharide vaccine for children above 2 years old to prevent epidemic cerebrospinal meningitis caused by Neisseria meningitidis group A, C, Y, and W135. The company also offers haemophilus influenzae type b conjugate vaccine for children from the age of 2 months to 5 years for the prevention of infectious diseases, including meningitis, pneumonia, septicemia, cellulitis, arthritis, epiglottitis, etc. In addition, it provides diphtheria, tetanus, and acellular pertussis combined vaccine for the prevention of diphtheria, tetanus, and pertussis for individuals from the age of 3 months to 6 years; and 23-valent pneumococcal polysaccharide vaccine for children above 2 years old to prevent pneumococcal disease caused by 23 serotypes. Walvax Biotechnology Co., Ltd. was founded in 2001 and is headquartered in Kunming, China.
300142.SZ Financial Timeline
Browse a chronological timeline of Walvax Biotechnology Co., Ltd. corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 25 Aug 2025
EPS came in at ¥0.03 falling short of the estimated ¥0.11 by -72.73%, while revenue for the quarter reached ¥691.96M , missing expectations by -15.76%.
Dividend declared on 28 May 2025
A dividend of ¥0.01 per share was announced, adjusted to ¥0.01. The dividend was paid on 28 May 2025.
Earnings released on 25 Apr 2025
EPS came in at -¥0.07 falling short of the estimated ¥0.05 by -242.82%, while revenue for the quarter reached ¥680.10M , beating expectations by +5.09%.
Earnings released on 11 Apr 2025
EPS came in at -¥0.07 falling short of the estimated -¥0.06 by -16.67%, while revenue for the quarter reached ¥462.26M , missing expectations by -35.23%.
Earnings released on 25 Oct 2024
EPS came in at ¥0.05 falling short of the estimated ¥0.06 by -16.67%, while revenue for the quarter reached ¥708.00M , missing expectations by -32.22%.
Earnings released on 28 Aug 2024
EPS came in at ¥0.10 falling short of the estimated ¥0.25 by -60.00%, while revenue for the quarter reached ¥828.42M , missing expectations by -43.50%.
Dividend declared on 30 May 2024
A dividend of ¥0.01 per share was announced, adjusted to ¥0.01. The dividend was paid on 30 May 2024.
Earnings released on 25 Apr 2024
EPS came in at ¥0.01 falling short of the estimated ¥0.11 by -90.91%, while revenue for the quarter reached ¥595.58M , missing expectations by -26.65%.
Earnings released on 30 Mar 2024
EPS came in at -¥0.08 matching the estimated -¥0.08, while revenue for the quarter reached ¥949.07M , beating expectations by +2.64%.
Earnings released on 25 Oct 2023
EPS came in at ¥0.06 falling short of the estimated ¥0.19 by -68.42%, while revenue for the quarter reached ¥990.37M , missing expectations by -39.78%.
Earnings released on 25 Aug 2023
EPS came in at ¥0.18 falling short of the estimated ¥0.19 by -5.26%, while revenue for the quarter reached ¥1.33B , missing expectations by -37.42%.
Dividend declared on 11 May 2023
A dividend of ¥0.01 per share was announced, adjusted to ¥0.01. The dividend was paid on 11 May 2023.
Earnings released on 24 Apr 2023
EPS came in at ¥0.11 surpassing the estimated ¥0.04 by +167.51%, while revenue for the quarter reached ¥833.27M , missing expectations by -12.23%.
Earnings released on 29 Mar 2023
EPS came in at ¥0.12 falling short of the estimated ¥0.15 by -20.00%, while revenue for the quarter reached ¥1.38B .
Earnings released on 25 Oct 2022
EPS came in at ¥0.08 falling short of the estimated ¥0.19 by -57.89%, while revenue for the quarter reached ¥1.36B , missing expectations by -18.33%.
Earnings released on 10 Aug 2022
EPS came in at ¥0.24 falling short of the estimated ¥0.26 by -7.69%, while revenue for the quarter reached ¥1.69B , missing expectations by 0.00%.
Earnings released on 28 Apr 2022
EPS came in at ¥0.02 falling short of the estimated ¥0.12 by -83.33%, while revenue for the quarter reached ¥655.89M , missing expectations by -32.64%.
Dividend declared on 26 Apr 2022
A dividend of ¥0.03 per share was announced, adjusted to ¥0.03. The dividend was paid on 26 Apr 2022.
Earnings released on 18 Mar 2022
EPS came in at ¥0.04 surpassing the estimated ¥0.02 by +100.00%, while revenue for the quarter reached ¥1.33B , beating expectations by +0.10%.
Earnings released on 28 Oct 2021
EPS came in at ¥0.03 , while revenue for the quarter reached ¥779.49M .
Earnings released on 30 Aug 2021
EPS came in at ¥0.18 , while revenue for the quarter reached ¥916.18M .
Dividend declared on 19 May 2021
A dividend of ¥0.05 per share was announced, adjusted to ¥0.05. The dividend was paid on 19 May 2021.
Earnings released on 27 Apr 2021
EPS came in at ¥0.02 , while revenue for the quarter reached ¥433.57M .
Earnings released on 26 Mar 2021
EPS came in at ¥0.36 surpassing the estimated ¥0.32 by +12.50%, while revenue for the quarter reached ¥1.37B .
Earnings released on 20 Oct 2020
EPS came in at ¥0.24 , while revenue for the quarter reached ¥993.31M .
Dividend declared on 30 Sept 2020
A dividend of ¥0.02 per share was announced, adjusted to ¥0.02. The dividend was paid on 30 Sept 2020.
300142.SZ Stock Performance
Access detailed 300142.SZ performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.